Charlotte Woodward Organ Transplant Discrimination Prevention Act
Summary
S.1782, the Charlotte Woodward Organ Transplant Discrimination Prevention Act, was reported favorably out of the Senate HELP Committee on June 17, 2026. The bill prohibits discrimination based on disability in organ transplant eligibility, requiring covered healthcare entities to make reasonable modifications. No direct funding is authorized; the impact is regulatory compliance for transplant hospitals and providers.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.S.1782 is a regulatory compliance bill, not a funding bill
- 2.Transplant hospitals and providers must adjust eligibility protocols
- 3.Bipartisan support increases likelihood of passage
Market Implications
The bill is neutral for healthcare sector stocks in the near term. No direct financial impact is authorized. Investors should monitor floor action and potential amendments. The regulatory burden is modest and unlikely to materially affect earnings for large-cap healthcare companies like UNH or JNJ.
Full Analysis
- What happened: On June 17, 2026, the Senate Committee on Health, Education, Labor, and Pensions ordered S.1782 to be reported favorably with an amendment. The bill, introduced by Sen. Moody (R-FL) with 21 cosponsors, now awaits floor action. It is a companion to H.R.1520 in the House. 2) Money trail: The bill does not authorize or appropriate any funding. It imposes a regulatory mandate on covered entities (hospitals, transplant centers, health care providers) to not discriminate on the basis of disability in organ transplant eligibility. 3) Structural winners and losers: The primary impact is on transplant hospitals and healthcare providers. HCA, UNH, and JNJ are affected as they operate or supply transplant services. The bill removes barriers for disabled individuals, potentially increasing the pool of eligible transplant candidates, which could drive modest volume growth for transplant-related drugs and services. 4) No real market data provided; analysis is based on legislative structure. 5) Timeline: The bill must pass the full Senate, then the House (companion H.R.1520 is also in committee), then be signed by the President. Given the bipartisan sponsorship (21 cosponsors including both parties), passage is plausible but not guaranteed.
Intelligence Surface
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
No confirming evidence found yet from contracts, insider trades, or congressional activity
What the bill does
Prohibition on discrimination based on disability in organ transplant eligibility criteria
Who must act
Covered entities including licensed health care providers, hospitals, nursing facilities, laboratories, and transplant hospitals
What happens
Mandates that transplant hospitals and providers cannot deny or delay organ transplants based on disability status; requires reasonable modifications to policies and practices for qualified individuals with disabilities
Stock impact
HCA operates a large network of hospitals and transplant centers; the bill imposes compliance and operational costs to adjust transplant eligibility protocols, but may increase patient volume for transplant services as barriers are removed
Key Legislators
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Accelerating Access To Veterans' Benefits And Employment Opportunities
This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.
Delivering Gold Standard Childhood Vaccine Recommendations for Americans
This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.
Continuing to Protect the Meaning and Value of American Citizenship
This executive order directs federal agencies, including State, Justice, Homeland Security, and Social Security, to deny U.S. citizenship documentation to children born in the U.S. whose parents include alien enemies, foreign government employees, or those involved in commercial birth tourism or surrogacy, or who are born in territories without statutory citizenship. It implements a narrow interpretation of the Fourteenth Amendment following the Supreme Court's decision in Trump v. Barbara, effectively restricting birthright citizenship for specific categories of non-citizen parents.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →